Advanced search
Publication Cover
Journal of Pain & Palliative Care Pharmacotherapy Volume 24, 2010 - Issue 1
Submit an article Journal homepage
1,007
Views
52
CrossRef citations to date
0
Altmetric
ARTICLE

Costs of Opioid Abuse and Misuse Determined From a Medicaid Database

Carrie McAdam-Marx Carrie McAdam-Marx, RPh, PhD, is Research Assistant Professor of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA; Carl L. Roland, PharmD, is Senior Director, Neurosciences Medical Development at King Pharmaceuticals, Inc., Cary, North Carolina, USA; Jody Cleveland, MS, is Biostatistician at King Pharmaceuticals, Inc.; and Gary M. Oderda, PharmD, MPH, is Professor of Pharmacotherapy and Director, Pharmacotherapy Outcomes Research Center, University of Utah.Correspondence[email protected]
,
Carl L. Roland Carrie McAdam-Marx, RPh, PhD, is Research Assistant Professor of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA; Carl L. Roland, PharmD, is Senior Director, Neurosciences Medical Development at King Pharmaceuticals, Inc., Cary, North Carolina, USA; Jody Cleveland, MS, is Biostatistician at King Pharmaceuticals, Inc.; and Gary M. Oderda, PharmD, MPH, is Professor of Pharmacotherapy and Director, Pharmacotherapy Outcomes Research Center, University of Utah.
,
Jody Cleveland Carrie McAdam-Marx, RPh, PhD, is Research Assistant Professor of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA; Carl L. Roland, PharmD, is Senior Director, Neurosciences Medical Development at King Pharmaceuticals, Inc., Cary, North Carolina, USA; Jody Cleveland, MS, is Biostatistician at King Pharmaceuticals, Inc.; and Gary M. Oderda, PharmD, MPH, is Professor of Pharmacotherapy and Director, Pharmacotherapy Outcomes Research Center, University of Utah.
&
Gary M. Oderda Carrie McAdam-Marx, RPh, PhD, is Research Assistant Professor of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA; Carl L. Roland, PharmD, is Senior Director, Neurosciences Medical Development at King Pharmaceuticals, Inc., Cary, North Carolina, USA; Jody Cleveland, MS, is Biostatistician at King Pharmaceuticals, Inc.; and Gary M. Oderda, PharmD, MPH, is Professor of Pharmacotherapy and Director, Pharmacotherapy Outcomes Research Center, University of Utah.
Pages 5-18 | Received 04 Nov 2009, Published online: 26 Mar 2010

Citations (52)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (14)

Gary J. Young, Md Mahmudul Hasan, Leonard D. Young & Md. Noor-E-Alam. (2023) Treatment Experiences for Patients Receiving Buprenorphine/Naloxone for Opioid Use Disorder: A Qualitative Study of Patients’ Perceptions and Attitudes. Substance Use & Misuse 58:4, pages 512-519.
Read now
Md Mahmudul Hasan, Md. Noor-E-Alam, Jiesheng Shi, Leonard D. Young & Gary J. Young. (2022) Long-term patient outcomes following buprenorphine/naloxone treatment for opioid use disorder: a retrospective analysis in a commercially insured population. The American Journal of Drug and Alcohol Abuse 48:4, pages 481-491.
Read now
M. Macmurdo, R. Lopez, B. L. Udeh & J. Zein. (2022) Beyond tobacco – the secondary impact of substance misuse in chronic obstructive lung disease. Journal of Asthma 59:2, pages 223-229.
Read now
Alejandro Salazar, Soledad Moreno, Helena De Sola, Jose Antonio Moral-Munoz, María Dueñas & Inmaculada Failde. (2020) The evolution of opioid-related mortality and potential years of life lost in Spain from 2008 to 2017: differences between Spain and the United States. Current Medical Research and Opinion 36:2, pages 285-291.
Read now
Akiko Kamimura, Samin Panahi, Naveen Rathi, Shannon Weaver, Mu Pye, Kai Sin & Jeanie Ashby. (2020) Risks of opioid abuse among uninsured primary care patients utilizing a free clinic. Journal of Ethnicity in Substance Abuse 19:1, pages 58-69.
Read now
Naoko A Ronquest, Tina M Willson, Leslie B Montejano, Vijay R Nadipelli & Bernd A Wollschlaeger. (2018) Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder. Substance Abuse and Rehabilitation 9, pages 59-78.
Read now
Elizabeth T. Masters, Arvind Ramaprasan, Jack Mardekian, Roy E. Palmer, David E. Gross, David Cronkite, Michael Von Korff & David S. Carrell. (2018) Natural Language Processing–Identified Problem Opioid Use and Its Associated Health Care Costs. Journal of Pain & Palliative Care Pharmacotherapy 32:2-3, pages 106-115.
Read now
Carl L. Roland, Joanita Lake & Gary M. Oderda. (2016) Prevalence of Prescription Opioid Misuse/Abuse as Determined by International Classification of Diseases Codes: A Systematic Review. Journal of Pain & Palliative Care Pharmacotherapy 30:4, pages 258-268.
Read now
Jordan B. King, Amy M. Sainski-Nguyen & Brandon K. Bellows. (2016) Office-Based Buprenorphine Versus Clinic-Based Methadone: A Cost-Effectiveness Analysis. Journal of Pain & Palliative Care Pharmacotherapy 30:1, pages 55-65.
Read now
Gary M. Oderda, Joanita Lake, Katja Rüdell, Carl L. Roland & Elizabeth T. Masters. (2015) Economic Burden of Prescription Opioid Misuse and Abuse: A Systematic Review. Journal of Pain & Palliative Care Pharmacotherapy 29:4, pages 388-400.
Read now
Shellie L. Keast, Nancy Nesser & Kevin Farmer. (2015) Strategies aimed at controlling misuse and abuse of opioid prescription medications in a state Medicaid program: a policymaker’s perspective. The American Journal of Drug and Alcohol Abuse 41:1, pages 1-6.
Read now
J. Bradford Rice, Noam Y. Kirson, Amie Shei, Caroline J. Enloe, Alice Kate G. Cummings, Howard G. Birnbaum, Pamela Holly & Rami Ben-Joseph. (2014) The Economic Burden of Diagnosed Opioid Abuse Among Commercially Insured Individuals. Postgraduate Medicine 126:4, pages 53-58.
Read now
Hitesh S. Chandwani, Scott A. Strassels, Karen L. Rascati, Kenneth A. Lawson & James P. Wilson. (2013) Estimates of Charges Associated With Emergency Department and Hospital Inpatient Care for Opioid Abuse-Related Events. Journal of Pain & Palliative Care Pharmacotherapy 27:3, pages 206-213.
Read now
Brandon K. Bellows & Joseph Biskupiak. (2011) Methodological Challenges of Comparative Effectiveness Research in Pain: Implications for Investigators, Clinicians, and Policy Makers. Journal of Pain & Palliative Care Pharmacotherapy 25:3, pages 267-274.
Read now

Articles from other publishers (38)

Mohammad Usama Toseef, Josh Durfee, Laura Jean Podewils, Joshua Blum, Dean McEwen, Rebecca Hanratty & Rachel Everhart. (2023) Total cost of care associated with opioid use disorder treatment. Preventive Medicine 166, pages 107345.
Crossref
Ralph Ward, David Taber, Haley Gonzales, Mulugeta Gebregziabher, William Basco, Jenna McCauley, Patrick Mauldin & Sarah Ball. (2022) Risk factors and trajectories of opioid use following total knee replacement. Knee Surgery & Related Research 34:1.
Crossref
Ingrid A. Binswanger, Deborah Rinehart, Shane R. Mueller, Komal J. Narwaney, Melanie Stowell, Nicole Wagner, Stan Xu, Rebecca Hanratty, Josh Blum, Kevin McVaney & Jason M. Glanz. (2022) Naloxone Co-Dispensing with Opioids: a Cluster Randomized Pragmatic Trial. Journal of General Internal Medicine 37:11, pages 2624-2633.
Crossref
Richa Jalodia, Yaa Fosuah Abu, Mark Ryan Oppenheimer, Bridget Herlihy, Jingjing Meng, Irina Chupikova, Junyi Tao, Nillu Ghosh, Rajib Kumar Dutta, Udhghatri Kolli, Yan Yan, Eridania Valdes, Madhulika Sharma, Umakant Sharma, Shamsudheen Moidunny & Sabita Roy. (2022) Opioid Use, Gut Dysbiosis, Inflammation, and the Nervous System. Journal of Neuroimmune Pharmacology 17:1-2, pages 76-93.
Crossref
Md Mahmudul Hasan, Gary J. Young, Jiesheng Shi, Prathamesh Mohite, Leonard D. Young, Scott G. Weiner & Md. Noor-E-Alam. (2021) A machine learning based two-stage clinical decision support system for predicting patients’ discontinuation from opioid use disorder treatment: retrospective observational study. BMC Medical Informatics and Decision Making 21:1.
Crossref
Md Mahmudul Hasan, Md. Noor-E-Alam, Prathamesh Mohite, Md Saiful Islam, Alicia Sasser Modestino, Alyssa M. Peckham, Leonard D. Young & Gary J. Young. (2021) Patterns of patient discontinuation from buprenorphine/naloxone treatment for opioid use disorder: A study of a commercially insured population in Massachusetts. Journal of Substance Abuse Treatment 131, pages 108416.
Crossref
Julie G. Pilitsis, Olga Khazen & Nikolai G. Wenzel. (2021) Multidisciplinary Firms and the Treatment of Chronic Pain: A Case Study of Low Back Pain. Frontiers in Pain Research 2.
Crossref
Jing Xu, Nazik M. A. Zakari, Hanadi Y. Hamadi, Sinyoung Park, Donald Rob Haley & Mei Zhao. (2021) The Financial Burden of Opioid-Related Abuse among Surgical and Non-Surgical Patients in Florida: A Longitudinal Study. International Journal of Environmental Research and Public Health 18:17, pages 9127.
Crossref
Aziza Arifkhanova, Emily McCormick Kraus, Alia Al-Tayyib, Julie Taub, Annette Encinias, Dean McEwen, Arthur Davidson & Judith C. Shlay. (2021) Estimating costs of hospitalizations associated with opioid use disorder or opioid misuse at a large, urban safety-net hospital—Denver, Colorado, 2017. Drug and Alcohol Dependence 218, pages 108306.
Crossref
Lorraine I. Kelley-Quon, Matthew G. Kirkpatrick, Robert L. Ricca, Robert Baird, Calista M. Harbaugh, Ashley Brady, Paula Garrett, Hale Wills, Jonathan Argo, Karen A. Diefenbach, Marion C.W. Henry, Juan E. Sola, Elaa M. Mahdi, Adam B. Goldin, Shawn D. St Peter, Cynthia D. Downard, Kenneth S. Azarow, Tracy Shields & Eugene Kim. (2021) Guidelines for Opioid Prescribing in Children and Adolescents After Surgery. JAMA Surgery 156:1, pages 76.
Crossref
John A. Carter, Libby K. Black, Dolly Sharma, Tarun Bhagnani & Jonathan S. Jahr. (2020) Efficacy of non-opioid analgesics to control postoperative pain: a network meta-analysis. BMC Anesthesiology 20:1.
Crossref
Sean M. Murphy. (2020) The cost of opioid use disorder and the value of aversion. Drug and Alcohol Dependence 217, pages 108382.
Crossref
Joseph Nuamah, Ranjana Mehta & Farzan Sasangohar. (2020) Technologies for Opioid Use Disorder Management: Mobile App Search and Scoping Review. JMIR mHealth and uHealth 8:6, pages e15752.
Crossref
Mark A. Brandenburg. (2020) American Indian and Non-Hispanic White Midlife Mortality Is Associated With Medicaid Spending: An Oklahoma Ecological Study (1999–2016). Frontiers in Public Health 8.
Crossref
Yaser Mohammed Al-Worafi. 2020. Drug Safety in Developing Countries. Drug Safety in Developing Countries 187 195 .
Joseph K. Nuamah, Farzan Sasangohar, Madhav Erraguntla & Ranjana K. Mehta. (2019) The past, present and future of opioid withdrawal assessment: a scoping review of scales and technologies. BMC Medical Informatics and Decision Making 19:1.
Crossref
Joseph HomsiEthan Y. BrovmanNikhilesh RaoEdward E. WhangRichard D. Urman. (2019) The Association Between Potential Opioid-Related Adverse Drug Events and Outcomes in Colorectal Surgery. Journal of Laparoendoscopic & Advanced Surgical Techniques 29:11, pages 1436-1445.
Crossref
Mark R. Jones, Ethan Y. Brovman, Matthew B. Novitch, Nikhilesh Rao & Richard D. Urman. (2019) Potential opioid-related adverse events following spine surgery in elderly patients. Clinical Neurology and Neurosurgery 186, pages 105550.
Crossref
Yea-Jen HsuJill A. MarstellerSarah G. KachurMichael I. Fingerhood. (2019) Integration of Buprenorphine Treatment with Primary Care: Comparative Effectiveness on Retention, Utilization, and Cost. Population Health Management 22:4, pages 292-299.
Crossref
Brent A. Metfessel, Michelle D. Mentel, Amy Phanel, Mary Ann Dimartino, Mureen Allen & Samuel Ho. (2018) Opioid Use is Associated with Higher Severity-Adjusted Episode Costs in Patients with Conservatively Managed Degenerative Joint Disease of the Back and Neck. PharmacoEconomics 37:3, pages 419-433.
Crossref
Carl L. RolandXiangyang YeVanessa StevensGary M. Oderda. (2019) The Prevalence and Cost of Medicare Beneficiaries Diagnosed and At Risk for Opioid Abuse, Dependence, and Poisoning. Journal of Managed Care & Specialty Pharmacy 25:1, pages 18-27.
Crossref
Hsien-Yen Chang, Hadi Kharrazi, Dave Bodycombe, Jonathan P. Weiner & G. Caleb Alexander. (2018) Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study. BMC Medicine 16:1.
Crossref
Timothy T. Pham, Grant H. Skrepnek, Christopher Bond, Thomas Alfieri, Terry J. Cothran & Shellie L. Keast. (2018) Overview of Prescription Opioid Deaths in the Oklahoma State Medicaid Population, 2012–2016. Medical Care 56:8, pages 727-735.
Crossref
Lillian Gelberg, Ronald M. Andersen, Melvin W. Rico, Mani Vahidi, Guillermina Natera Rey, Steve Shoptaw, Barbara D. Leake, Martin Serota, Kyle Singleton & Sebastian E. Baumeister. (2017) A pilot replication of QUIT, a randomized controlled trial of a brief intervention for reducing risky drug use, among Latino primary care patients. Drug and Alcohol Dependence 179, pages 433-440.
Crossref
Shellie L. KeastTimothy PhamAshley TeelNancy J. Nesser. (2017) Incremental Effect of the Addition of Prescriber Restrictions on a State Medicaid’s Pharmacy-Only Patient Review and Restriction Program. Journal of Managed Care & Specialty Pharmacy 23:8, pages 875-883.
Crossref
Mary Kate Mohlman, Beth Tanzman, Karl Finison, Melanie Pinette & Craig Jones. (2016) Impact of Medication-Assisted Treatment for Opioid Addiction on Medicaid Expenditures and Health Services Utilization Rates in Vermont. Journal of Substance Abuse Treatment 67, pages 9-14.
Crossref
Shellie L. Keast, Arthur Owora, Nancy Nesser & Kevin Farmer. (2016) Evaluation of Abuse-Deterrent or Tamper-Resistant Opioid Formulations on Overall Health Care Expenditures in a State Medicaid Program. Journal of Managed Care & Specialty Pharmacy 22:4, pages 347-356.
Crossref
Arthur Lipman & Lynn Webster. (2015) The Economic Impact of Opioid Use in the Management of Chronic Nonmalignant Pain. Journal of Managed Care & Specialty Pharmacy 21:10, pages 891-899.
Crossref
Mariano E. Menendez, David Ring & Brian T. Bateman. (2015) Preoperative Opioid Misuse is Associated With Increased Morbidity and Mortality After Elective Orthopaedic Surgery. Clinical Orthopaedics and Related Research? 473:7, pages 2402-2412.
Crossref
Jeffrey Vietri, Ashish V. Joshi, Alexandra I. Barsdorf & Jack Mardekian. (2014) Prescription Opioid Abuse and Tampering in the United States: Results of a Self-Report Survey. Pain Medicine 15:12, pages 2064-2074.
Crossref
Roxanne MeyerAnisha M. PatelStacy K. RattanaTiffany P. QuockSamir H. Mody. (2014) Prescription Opioid Abuse: A Literature Review of the Clinical and Economic Burden in the United States. Population Health Management 17:6, pages 372-387.
Crossref
J. Bradford Rice, Noam Y. Kirson, Amie Shei, Alice Kate G. Cummings, Katharine Bodnar, Howard G. Birnbaum & Rami Ben-Joseph. (2014) Estimating the Costs of Opioid Abuse and Dependence from an Employer Perspective: a Retrospective Analysis Using Administrative Claims Data. Applied Health Economics and Health Policy 12:4, pages 435-446.
Crossref
Robert Dufour, Ashish V. Joshi, Margaret K. Pasquale, David Schaaf, Jack Mardekian, George A. Andrews & Nick C. Patel. (2014) The Prevalence of Diagnosed Opioid Abuse in Commercial and Medicare Managed Care Populations. Pain Practice 14:3, pages E106-E115.
Crossref
Margaret K. Pasquale, Ashish V. Joshi, Robert Dufour, David Schaaf, Jack Mardekian, George A. Andrews & Nick C. Patel. (2014) Cost Drivers of Prescription Opioid Abuse in Commercial and Medicare Populations. Pain Practice 14:3, pages E116-E125.
Crossref
Timothy J. Inocencio, Norman V. Carroll, Edward J. Read & David A. Holdford. (2013) The Economic Burden of Opioid-Related Poisoning in the United States. Pain Medicine 14:10, pages 1534-1547.
Crossref
Mohammad Reza Masjedi, Parisa Adimi Naghan, Shervin Taslimi, Mahmoud Yousefifard, Seyyed Meisam Ebrahimi, Adnan Khosravi, Shirin Karimi, Mostafa Hosseini & Esmaeil Mortaz. (2013) Opium Could Be Considered an Independent Risk Factor for Lung Cancer: A Case-Control Study. Respiration 85:2, pages 112-118.
Crossref
Gary Oderda. (2012) Challenges in the Management of Acute Postsurgical Pain. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32:9pt2, pages 6S-11S.
Crossref
Howard G. Birnbaum, Alan G. White, Matt Schiller, Tracy Waldman, Jody M. Cleveland & Carl L. Roland. (2011) Societal Costs of Prescription Opioid Abuse, Dependence, and Misuse in the United States. Pain Medicine 12:4, pages 657-667.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.